Masters Tickets to Benefit ALS Research Offered by Watson, Edwards and Julian

    CAMBRIDGE, Mass., April 3 /PRNewswire/ -- Driving 4 Life, the ALS
 fundraising campaign supported by World Hall of Fame Golfer Tom Watson, his
 caddy Bruce Edwards and former PGA TOUR Pro Jeff Julian, is providing a chance
 for golf fans nationwide to receive the most sought after tickets in sports --
 the 2004 Masters Tournament at Augusta National.  Driving 4 Life and the ALS
 Therapy Development Foundation are holding a raffle at www.driving4life.org to
 award the following to the holder of the winning ticket chosen on Monday April
 5th at 5:00pm EST.
 
      * Two Masters Tournament badges for Sunday April 11th
      * Accommodations in private residence in Augusta on Saturday April 10th
      * Complimentary local transportation in Augusta for the weekend
      * Each raffle ticket is $50.
 
     The Masters Tournament is significant for both Bruce Edwards and Jeff
 Julian, who have both been diagnosed with ALS.  Last year, Jeff Julian
 received the Golf Writers Association of America's Ben Hogan Award, given
 annually to an individual who has continued to be active in golf despite a
 physical handicap or serious illness.  This year, Bruce Edwards will be
 receiving the Ben Hogan Award.  Bruce Edwards's life is chronicled in a new
 book by best-selling sportswriter John Feinstein.  CADDY FOR LIFE: The Bruce
 Edwards Story will be available in bookstores everywhere on Tuesday, April 6.
     There is currently no cure for ALS, in which the body's nervous system
 gradually degenerates, robbing its victims of the ability to walk, speak and,
 eventually, swallow or breathe.  Most ALS victims live two to five years after
 diagnosis.
     Proceeds from the raffle will directly benefit the ALS Therapy Development
 Foundation (ALSTDF), the leading drug discovery center for today's ALS
 patients.  James Heywood, whose brother, Stephen, was diagnosed with ALS,
 founded ALSTDF in 1999.  The nonprofit biotechnology company researches and
 screens drugs, and develops pre-clinical and clinical trials to translate
 these drugs into potential treatments for ALS victims.  For more information
 on the ALS Therapy Development Foundation, please visit www.als.net.
 
     Press Contact:  Tyson Goodridge
                     tgoodridge@als.net
 
 

SOURCE  ALS Therapy Development Foundation